Joel A Sincavage

Array ( [id] => 5672976 [patent_doc_number] => 20060178331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Antisense oligonucleotides targeting folate receptor alpha, and the use thereof' [patent_app_type] => utility [patent_app_number] => 11/328449 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9459 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20060178331.pdf [firstpage_image] =>[orig_patent_app_number] => 11328449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095059 [patent_doc_number] => 20070116668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Lymphotoxin-beta, lymphotoxin-beta Complexes, pharmaceutical preparations and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 11/313230 [patent_app_country] => US [patent_app_date] => 2005-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 21036 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116668.pdf [firstpage_image] =>[orig_patent_app_number] => 11313230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4580247 [patent_doc_number] => 07834064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-16 [patent_title] => 'Clinical method for the immunomodulatory and vaccine adjuvant use of poly-ICLC and other dsRNAs' [patent_app_type] => utility [patent_app_number] => 11/291851 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 9967 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 200 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/834/07834064.pdf [firstpage_image] =>[orig_patent_app_number] => 11291851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5485866 [patent_doc_number] => 20090275631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'THERAPEUTIC ANTISENSE OLIGONUCLEOTIDE COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 11/720745 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9404 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20090275631.pdf [firstpage_image] =>[orig_patent_app_number] => 11720745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843184 [patent_doc_number] => 20060121510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Multidomain polynucleotide molecular sensors' [patent_app_type] => utility [patent_app_number] => 11/288869 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 17064 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121510.pdf [firstpage_image] =>[orig_patent_app_number] => 11288869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4527690 [patent_doc_number] => 07923206 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Method of determining a cellular response to a biological agent' [patent_app_type] => utility [patent_app_number] => 11/283481 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20044 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 331 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923206.pdf [firstpage_image] =>[orig_patent_app_number] => 11283481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4527716 [patent_doc_number] => 07923207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Apparatus and system having dry gene silencing pools' [patent_app_type] => utility [patent_app_number] => 11/283482 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17764 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923207.pdf [firstpage_image] =>[orig_patent_app_number] => 11283482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5874079 [patent_doc_number] => 20060166234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Apparatus and system having dry control gene silencing compositions' [patent_app_type] => utility [patent_app_number] => 11/283483 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 20812 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166234.pdf [firstpage_image] =>[orig_patent_app_number] => 11283483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8538352 [patent_doc_number] => 08314073 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-20 [patent_title] => 'Cancer-cell-specific cell proliferation inhibitors' [patent_app_type] => utility [patent_app_number] => 11/791129 [patent_app_country] => US [patent_app_date] => 2005-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6793 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11791129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4455549 [patent_doc_number] => 07892793 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Allele-specific RNA interference' [patent_app_type] => utility [patent_app_number] => 11/241873 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 19 [patent_no_of_words] => 31390 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892793.pdf [firstpage_image] =>[orig_patent_app_number] => 11241873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520881 [patent_doc_number] => 20090028862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'Emmprin antagonists and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/664150 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 20012 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028862.pdf [firstpage_image] =>[orig_patent_app_number] => 11664150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 311094 [patent_doc_number] => 07528118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-05 [patent_title] => 'RNAi modulation of ApoB and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/235385 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 41087 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/528/07528118.pdf [firstpage_image] =>[orig_patent_app_number] => 11235385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5409674 [patent_doc_number] => 20090123572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Method and Pharmaceutical Composition for Treating Psoriasis, Squamous Cell Carcinoma and/or Parakeratosis by Inhibiting Expression of Squamous Cell Carcinoma-Related Antigen' [patent_app_type] => utility [patent_app_number] => 11/886475 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14702 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123572.pdf [firstpage_image] =>[orig_patent_app_number] => 11886475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5799312 [patent_doc_number] => 20060034843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Interaction of Smad6 with Hox proteins and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/227664 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5505 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034843.pdf [firstpage_image] =>[orig_patent_app_number] => 11227664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865483 [patent_doc_number] => 20060099613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Use of antisense oligonucleotide libraries for identifying gene function' [patent_app_type] => utility [patent_app_number] => 11/223337 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29501 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099613.pdf [firstpage_image] =>[orig_patent_app_number] => 11223337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662124 [patent_doc_number] => 20060252720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Modulation of HIF1 beta expression' [patent_app_type] => utility [patent_app_number] => 11/213593 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30340 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252720.pdf [firstpage_image] =>[orig_patent_app_number] => 11213593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5820414 [patent_doc_number] => 20060024727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Antisense modulation of C-reactive protein expression' [patent_app_type] => utility [patent_app_number] => 11/211803 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25462 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024727.pdf [firstpage_image] =>[orig_patent_app_number] => 11211803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4604602 [patent_doc_number] => 07985581 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-26 [patent_title] => 'Multiple RNA polymerase III promoter expression constructs' [patent_app_type] => utility [patent_app_number] => 11/660937 [patent_app_country] => US [patent_app_date] => 2005-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 22260 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/985/07985581.pdf [firstpage_image] =>[orig_patent_app_number] => 11660937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326777 [patent_doc_number] => 07514548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Methods of inhibiting COX-2' [patent_app_type] => utility [patent_app_number] => 11/194316 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8613 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514548.pdf [firstpage_image] =>[orig_patent_app_number] => 11194316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5667030 [patent_doc_number] => 20060172380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'TAB1 protein and DNA coding therefore' [patent_app_type] => utility [patent_app_number] => 11/180911 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6303 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172380.pdf [firstpage_image] =>[orig_patent_app_number] => 11180911 [rel_patent_id] =>[rel_patent_doc_number] =>)